-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Kymera Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2024.
- Kymera Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$57.8 M, a 27.6% decline year-over-year.
- Kymera Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$178 M, a 4.94% decline year-over-year.
- Kymera Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$166 M, a 2.65% decline from 2022.
- Kymera Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$161 M, a 60.4% decline from 2021.
- Kymera Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$101 M, a 117% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)